High-resolution analysis of the subtelomeric regions of human embryonic stem cells.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 15790769)

Published in Stem Cells on April 01, 2005

Authors

Catarina Darnfors1, Anna Flodin, Katarina Andersson, Gunilla Caisander, Jenny Lindqvist, Johan Hyllner, Jan Wahlström, Peter Sartipy

Author Affiliations

1: Department of Clinical Genetics, Sahlgrenska University Hospital East, 416-85 Göteborg, Sweden. catarina.darnfors@vgregion.se

Articles by these authors

Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol (2007) 9.36

CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N Engl J Med (2006) 5.89

Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol (2011) 3.97

Genomic alterations in cultured human embryonic stem cells. Nat Genet (2005) 3.89

Human embryonic stem cells have a unique epigenetic signature. Genome Res (2006) 2.89

T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis. J Immunol (2008) 1.52

Quantified proarrhythmic potential of selected human embryonic stem cell-derived cardiomyocytes. Stem Cell Res (2010) 1.51

Chromosomal integrity maintained in five human embryonic stem cell lines after prolonged in vitro culture. Chromosome Res (2006) 1.39

Creation of engineered human embryonic stem cell lines using phiC31 integrase. Stem Cells (2007) 1.35

Facilitated expansion of human embryonic stem cells by single-cell enzymatic dissociation. Stem Cells (2007) 1.32

Multiplex ligation-dependent probe amplification (MLPA) detects large deletions in the MECP2 gene of Swedish Rett syndrome patients. Genet Test (2003) 1.27

Derivation of a xeno-free human embryonic stem cell line. Stem Cells (2006) 1.26

Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG. J Mol Cell Cardiol (2012) 1.20

Differentiating human embryonic stem cells express a unique housekeeping gene signature. Stem Cells (2007) 1.18

Molecular signature of cardiomyocyte clusters derived from human embryonic stem cells. Stem Cells (2008) 1.16

Human embryonic stem cell-derived mesenchymal progenitors--potential in regenerative medicine. Stem Cell Res (2009) 1.16

Human embryonic mesodermal progenitors highly resemble human mesenchymal stem cells and display high potential for tissue engineering applications. Tissue Eng Part A (2010) 1.15

Improving expansion of pluripotent human embryonic stem cells in perfused bioreactors through oxygen control. J Biotechnol (2010) 1.12

Monitoring differentiation of human embryonic stem cells using real-time PCR. Stem Cells (2005) 1.11

The Karolinska cocktail for phenotyping of five human cytochrome P450 enzymes. Clin Pharmacol Ther (2003) 1.09

Differentiation of human embryonic stem cells to cardiomyocytes for in vitro and in vivo applications. Stem Cell Rev (2010) 1.09

Coculture of human embryonic stem cells and human articular chondrocytes results in significantly altered phenotype and improved chondrogenic differentiation. Stem Cells (2009) 1.06

A morphological and chromosomal study of blastocysts developing from morphologically suboptimal human pre-embryos compared with control blastocysts. Hum Reprod (2003) 1.04

The application of human embryonic stem cell technologies to drug discovery. Drug Discov Today (2007) 1.03

Publishing SNP genotypes of human embryonic stem cell lines: policy statement of the International Stem Cell Forum Ethics Working Party. Stem Cell Rev (2011) 1.02

Human embryonic stem cells and chromosome stability. APMIS (2006) 1.00

Human embryonic stem cell technologies and drug discovery. J Cell Physiol (2009) 1.00

Large-scale propagation of four undifferentiated human embryonic stem cell lines in a feeder-free culture system. Dev Dyn (2005) 0.96

Osteogenic potential of human mesenchymal stem cells and human embryonic stem cell-derived mesodermal progenitors: a tissue engineering perspective. Tissue Eng Part A (2010) 0.96

Global transcriptional profiling reveals similarities and differences between human stem cell-derived cardiomyocyte clusters and heart tissue. Physiol Genomics (2011) 0.95

Cardiotoxicity testing using pluripotent stem cell-derived human cardiomyocytes and state-of-the-art bioanalytics: a review. J Appl Toxicol (2011) 0.95

Novel findings in Swedish patients with MYH-associated polyposis: mutation detection and clinical characterization. Clin Gastroenterol Hepatol (2006) 0.93

Molecular and pharmacological properties of human embryonic stem cell-derived cardiomyocytes. Exp Biol Med (Maywood) (2006) 0.93

Human embryonic stem cell-derived mesenchymal stroma cells (hES-MSCs) engraft in vivo and support hematopoiesis without suppressing immune function: implications for off-the shelf ES-MSC therapies. PLoS One (2013) 0.93

Genome-wide linkage scan for breast cancer susceptibility loci in Swedish hereditary non-BRCA1/2 families: suggestive linkage to 10q23.32-q25.3. Genes Chromosomes Cancer (2007) 0.93

Human embryonic stem cells: current technologies and emerging industrial applications. Crit Rev Oncol Hematol (2007) 0.93

Blood group ABO antigen expression in human embryonic stem cells and in differentiated hepatocyte- and cardiomyocyte-like cells. Transplantation (2008) 0.93

A possible mechanism behind autoimmune disorders discovered by genome-wide linkage and association analysis in celiac disease. PLoS One (2013) 0.93

Adaptation of human embryonic stem cells to feeder-free and matrix-free culture conditions directly on plastic surfaces. J Biotechnol (2007) 0.92

Footprint-free human induced pluripotent stem cells from articular cartilage with redifferentiation capacity: a first step toward a clinical-grade cell source. Stem Cells Transl Med (2014) 0.92

Higher monocyte expression of TLR2 and TLR4, and enhanced pro-inflammatory synergy of TLR2 with NOD2 stimulation in sarcoidosis. J Clin Immunol (2008) 0.92

Meta and pooled analysis of European coeliac disease data. Eur J Hum Genet (2003) 0.91

Transplantation of human embryonic stem cells onto a partially wounded human cornea in vitro. Acta Ophthalmol (2012) 0.91

Identification of genomic deletions of the APC gene in familial adenomatous polyposis by two independent quantitative techniques. Genet Test (2004) 0.89

Restricted T cell receptor BV gene usage in the lungs and muscles of patients with idiopathic inflammatory myopathies. Arthritis Rheum (2007) 0.89

Clonal derivation and characterization of human embryonic stem cell lines. J Biotechnol (2005) 0.89

Analysis of chromosome 5q31-32 and psoriasis: confirmation of a susceptibility locus but no association with SNPs within SLC22A4 and SLC22A5. J Invest Dermatol (2006) 0.88

Low daily 10-mg and 20-mg doses of fluvoxamine inhibit the metabolism of both caffeine (cytochrome P4501A2) and omeprazole (cytochrome P4502C19). Clin Pharmacol Ther (2002) 0.88

No evidence of altered alveolar macrophage polarization, but reduced expression of TLR2, in bronchoalveolar lavage cells in sarcoidosis. Respir Res (2010) 0.87

Dislocation of bipolar hip hemiarthroplasty through a postero-lateral approach for femoral neck fractures: A cohort study. Int Orthop (2015) 0.87

Landscape of current and emerging cell therapy clinical trials in the UK: current status, comparison to global trends and future perspectives. Regen Med (2015) 0.87

Association analysis of cystatin A and zinc finger protein 148, two genes located at the psoriasis susceptibility locus PSORS5. J Invest Dermatol (2004) 0.86

Differential bone-forming capacity of osteogenic cells from either embryonic stem cells or bone marrow-derived mesenchymal stem cells. J Tissue Eng Regen Med (2010) 0.86

Mutations and sequence variation in the human myosin heavy chain IIa gene (MYH2). Eur J Hum Genet (2005) 0.86

Improvement of cardiac efficacy and safety models in drug discovery by the use of stem cell-derived cardiomyocytes. Expert Opin Drug Discov (2009) 0.85

Sustained embryoid body formation and culture in a non-laborious three dimensional culture system for human embryonic stem cells. Cytotechnology (2011) 0.85

Assaying cardiac biomarkers for toxicity testing using biosensing and cardiomyocytes derived from human embryonic stem cells. J Biotechnol (2010) 0.84

Frostbite injuries treated in the Helsinki area from 1995 to 2002. J Trauma (2004) 0.84

Regulation of 'stemness' and stem cell differentiation by microRNAs. IDrugs (2009) 0.83

New cell models and assays in cardiac safety profiling. Expert Opin Drug Metab Toxicol (2007) 0.83

Celiac disease confers a 1.6-fold increased risk of asthma: a nationwide population-based cohort study. J Allergy Clin Immunol (2011) 0.83

Superior osteogenic capacity of human embryonic stem cells adapted to matrix-free growth compared to human mesenchymal stem cells. Tissue Eng Part A (2010) 0.83

Expression of microRNAs and their target mRNAs in human stem cell-derived cardiomyocyte clusters and in heart tissue. Physiol Genomics (2010) 0.83

Collecting a set of psoriasis family material through a patient organisation; clinical characterisation and presence of additional disorders. BMC Dermatol (2005) 0.83

Transcriptional profiling of human embryonic stem cells differentiating to definitive and primitive endoderm and further toward the hepatic lineage. Stem Cells Dev (2010) 0.82

Cardiomyocyte clusters derived from human embryonic stem cells share similarities with human heart tissue. J Mol Cell Biol (2010) 0.82

A candidate region for Asperger syndrome defined by two 17p breakpoints. Eur J Hum Genet (2003) 0.82

A high frequency of germline BRCA1/2 mutations in western Sweden detected with complementary screening techniques. Fam Cancer (2005) 0.81

Altered expression of T cell immunoglobulin-mucin (TIM) molecules in bronchoalveolar lavage CD4+ T cells in sarcoidosis. Respir Res (2009) 0.81

Familial dyslexia in a large Swedish family: a whole genome linkage scan. Behav Genet (2010) 0.80

Cardiomyocytes derived from human embryonic stem cells - characteristics and utility for drug discovery. Curr Opin Drug Discov Devel (2009) 0.80

Antigen-specific multifunctional T-cells in sarcoidosis patients with Lofgren's syndrome. Eur Respir J (2011) 0.80

Human embryonic stem cell-derived mesodermal progenitors display substantially increased tissue formation compared to human mesenchymal stem cells under dynamic culture conditions in a packed bed/column bioreactor. Tissue Eng Part A (2012) 0.79

Testing potential developmental toxicants with a cytotoxicity assay based on human embryonic stem cells. Altern Lab Anim (2008) 0.79

A comprehensive screen for SNP associations on chromosome region 5q31-33 in Swedish/Norwegian celiac disease families. Eur J Hum Genet (2007) 0.79

Cardiomyogenic gene expression profiling of differentiating human embryonic stem cells. J Biotechnol (2007) 0.78

The establishment of 20 different human embryonic stem cell lines and subclones; a report on derivation, culture, characterisation and banking. In Vitro Cell Dev Biol Anim (2010) 0.78

Immunogenetics of Disease-Causing Inflammation in Sarcoidosis. Clin Rev Allergy Immunol (2015) 0.78

Human blastocysts for the development of embryonic stem cells. Reprod Biomed Online (2004) 0.77

A novel 3D label-free monitoring system of hES-derived cardiomyocyte clusters: a step forward to in vitro cardiotoxicity testing. PLoS One (2013) 0.77

Trends in the human embryonic stem cell patent field. Recent Pat Nanotechnol (2007) 0.77

Hypoxia but not cigarette smoke modulates VEGF secretion from human T cells. Growth Factors (2009) 0.77

Single cell enzymatic dissociation of human embryonic stem cells: a straightforward, robust, and standardized culture method. Methods Mol Biol (2010) 0.77

Low molecular weight compounds for in vitro fate determination of human embryonic stem cells. Pharmacol Res (2008) 0.77